We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+3.39%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$661M
AUM Growth
-$473M
Cap. Flow
-$486M
Cap. Flow %
-73.58%
Top 10 Hldgs %
6.77%
Holding
1,175
New
248
Increased
83
Reduced
484
Closed
358

Top Buys

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$3.58M
2
AZO icon
AutoZone
AZO
+$3.03M
3
HWM icon
Howmet Aerospace
HWM
+$2.87M
4
ANSS
Ansys
ANSS
+$2.84M
5
IT icon
Gartner
IT
+$2.66M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.61M
2
GM icon
General Motors
GM
+$6.29M
3
BG icon
Bunge Global
BG
+$5.38M
4
QCOM icon
Qualcomm
QCOM
+$5M
5
USFD icon
US Foods
USFD
+$4.97M

Sector Composition

Rank Sector Weight
1 Technology 21.14%
2 Healthcare 20.5%
3 Financials 14.07%
4 Industrials 12.62%
5 Consumer Discretionary 11.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DSEY
501
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
$394K 0.06%
+81,019
New +$515K
AMED
502
DELISTED
Amedisys
AMED
$393K 0.06%
4,065
-6,660
-62% -$794K
KTOS icon
503
Kratos Defense & Security Solutions
KTOS
$8.23B
$392K 0.06%
38,535
-10,465
-21% -$140K
STNE icon
504
StoneCo
STNE
$2.67B
$392K 0.06%
41,142
-84,391
-67% -$808K
AVIR icon
505
Atea Pharmaceuticals
AVIR
$370M
$391K 0.06%
+68,754
New +$526K
NSIT icon
506
Insight Enterprises
NSIT
$3.85B
$390K 0.06%
4,735
-3,561
-43% -$317K
OM icon
507
Outset Medical
OM
$86.4M
$390K 0.06%
1,634
-2,685
-62% -$719K
RVMD icon
508
Revolution Medicines
RVMD
$38.5B
$390K 0.06%
+19,778
New +$435K
WNC icon
509
Wabash National
WNC
$504M
$390K 0.06%
25,070
-29,956
-54% -$489K
OZK icon
510
Bank OZK
OZK
$5.63B
$387K 0.06%
9,790
-4,919
-33% -$198K
VITL icon
511
Vital Farms
VITL
$586M
$387K 0.06%
32,308
+2,023
+7% +$24.1K
PINC
512
DELISTED
Premier
PINC
$383K 0.06%
+11,294
New +$412K
ACAD icon
513
Acadia Pharmaceuticals
ACAD
$4.51B
$381K 0.06%
23,286
-63,722
-73% -$1.03M
MGNX icon
514
MacroGenics
MGNX
$233M
$381K 0.06%
110,054
-76,721
-41% -$293K
ADPT icon
515
Adaptive Biotechnologies
ADPT
$3.61B
$380K 0.06%
53,325
-6,568
-11% -$61.9K
FNV icon
516
Franco-Nevada
FNV
$41.3B
$380K 0.06%
3,177
+1,537
+94% +$193K
AKAM icon
517
Akamai
AKAM
$15.6B
$379K 0.06%
+4,721
New +$430K
SAGE
518
DELISTED
Sage Therapeutics
SAGE
$378K 0.06%
9,659
-75,502
-89% -$2.92M
DTM icon
519
DT Midstream
DTM
$13.9B
$376K 0.06%
+7,252
New +$391K
WAT icon
520
Waters Corp
WAT
$37.3B
$376K 0.06%
1,394
-1,191
-46% -$380K
AXSM icon
521
Axsome Therapeutics
AXSM
$11.7B
$375K 0.06%
8,397
-59,270
-88% -$2.96M
CF icon
522
CF Industries
CF
$19.6B
$373K 0.06%
3,878
-7,622
-66% -$744K
RAMP icon
523
LiveRamp
RAMP
$2.29B
$372K 0.06%
20,488
-28,219
-58% -$652K
CSII
524
DELISTED
Cardiovascular Systems, Inc.
CSII
$372K 0.06%
26,804
-20,418
-43% -$303K
AMPL icon
525
Amplitude
AMPL
$1.18B
$369K 0.06%
+23,850
New +$382K
19 20
21
22 23

Similar funds

ISS
Intesa Sanpaolo SpA. Turin, Italy $1.69B AUM
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
SGI
Summit Global Investments Bountiful, Utah $1.69B AUM 12.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

PDT Partners's Q3 2022 Portfolio in Review

As of Q3 2022, PDT Partners held 1,175 positions worth $661M, down 42% from $1.13B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

PDT Partners withdrew a net $486M in Q3 2022, closing 358 positions and reducing 484 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $7.61M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, PDT Partners opened a new position in Coupang worth $3.45M.

  • PDT Partners's largest Q3 2022 buy was Coupang: 207,142 shares worth $3.45M.
  • PDT Partners added most to AutoZone in Q3 2022, an estimated $3.03M increase.
  • PDT Partners's biggest Q3 2022 reduction was General Motors, cutting an estimated $6.29M.
  • PDT Partners fully exited Vertex Pharmaceuticals in Q3 2022, selling an estimated $7.61M.
  • PDT Partners's ten largest holdings make up 6.8% of its $661M portfolio in Q3 2022.
  • PDT Partners opened 248 new positions and closed 358 in Q3 2022.
  • PDT Partners's portfolio value fell 42% quarter-over-quarter to $661M.

Based on PDT Partners's 13F filing for Q3 2022, filed 14 Nov 2022.